HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

Molecular and Cellular Biology

Volumn 21, Issue 12, 2001, Pages 3995-4004

  Laughner, Erik ^a   Taghavi, Panthea ^a   Chiles, Kelly ^a   Mahon, Patrick C ^a   Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; RAPAMYCIN; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CANCER CELL; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HALF LIFE TIME; HUMAN; HUMAN CELL; HYPOXIA; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ANIMALS; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL HYPOXIA; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOKINES; MALE; MICE; NEUREGULIN-1; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0035012605     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.12.3995-4004.2001     Document Type: Article

References (68)

1. Aebersold, D. M., P. Burri, K. T. Beer, J. Laissue, V. Djonov, R. H. Greiner, and G. L. Semenza. 2001. Expression of hypoxia-inducible factor-1a: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61:2411-2916.
2. Agani, F., and G. L. Semenza. 1998. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. Mol. Pharmacol. 54:749-754.
3. Bagheri-Yarmand, R., R. K. Vadlamudi, R. A. Wang, J. Mendelsohn, and R. Kumar. 2000. Vascular endothelial growth factor upregulation via p21-activated kinase-1 signaling regulates heregulin-β1-mediated angiogenesis. J. Biol. Chem. 275:39451-39457.
4. Birner, P., M. Schindl, A. Obermair, C. Plank, G. Breitenecker, and G. Oberhuber. 2000. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 60:4693-4696.
5. Bos, R., H. Zhong, C. F. Hanrahan, E. C. M. Mommers, G. L. Semenza, H. M. Pinedo, M. D. Abeloff, J. W. Simons, P. J. van Diest, E. van der Wall. 2000. Levels of hypoxia-inducible factor 1α during breast carcinogenesis. J. Natl. Cancer lnst. 93:309-314.
6. Carmeliet, P., Y. Dor, J.-M. Herbert, D. Fukumura, K. Brusselmans, M. Dewerchin, M. Neeman, F. Bono, R. Abramovitch, P. Maxwell, C. J. Koch, P. Ratcliffe, L. Moons, R. K. Jain, D. Collen, and E. Keshet. 1998. Role of Hif-1α in hypoxia-mediated apoptosis, cell proliferation, and tumour angiogenesis. Nature 394:485-490.
7. Cockman, M. E., N. Masson, D. R. Mole, P. Jaakkola, G. W. Chang, S. C. Clifford, E. R. Maher, C. W. Pugh, P. J. Ratcliffe, and P. H. Maxwell. 2000. Hypoxia-inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275:25733-25741.
8. Dufner, A., and G. Thomas. 1999. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253:100-109.
9. Feldser, D., F. Agani, N. V. Iyer, B. Pak, G. Ferreira, and G. L. Semenza. 1999. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res. 59:3915-3918.
10. Ferrara, N., and T. Davis-Smyth. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4-25.
11. Fidler, I. J., and L. M. Ellis. 1994. The implication of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185-188.
12. Forsythe, J. A., B.-H. Jiang, N. V. Iyer, F. Agani, S. W. Leung, R. D. Koos, and G. L. Semenza. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-4613.
13. Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736.
14. Gingras, A.-C., S. P. Gygi, B. Raught, R. D. Polakiewicz, R. T. Abraham, M. F. Hoekstra, R. Aebersold, and N. Sonenberg. 1999. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13:1422-1437.
15. Guidi, A. J., L. Fischer, J. R. Harris, and S. J. Schnitt. 1994. Microvessel density and distribution in ductal carcinoma in situ of the breast. J. Natl. Cancer Inst. 86:614-619.
16. Hanahan, D., and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
17. Hara, K., K. Yonezawa, M. T. Kozlowski, T. Sugimoto, K. Andrabi, Q.-P. Weng, M. Kasuga, I. Nishimoto, and J. Avruch. 1997. Regulation of eIF-4E BP1 phosphorylation by mTOR. J. Biol. Chem. 272:26457-26463.
18. Harding, H. P., I. Novoa, Y. Zhang, H. Zeng, R. Wek, M. Schapira, and D. Ron. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6:1099-1108.
19. Horak, E. R., R. Leek, N. Klenk, S. LeJeune, K. Smith, N. Stuart, M. Greenall, K. Stepniewska, and A. L. Harris. 1992. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antiobodies, as an indicator of node metastases and survival in breast cancer. Lancet 340:1120-1124.
20. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95:7987-7992.
21. Hung, M. C., A. L. Schechter, P. Y. Chevray, D. F. Stern, and R. A. Weinberg. 1986. Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc. Natl. Acad. Sci. USA 83:261-264.
22. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev. 12:149-162.
23. Iyer, N. V., S. W. Leung, and G. L. Semenza. 1998. The human hypoxia-inducible factor 1α gene: HIFIA structure and evolutionary conservation. Genomics 52:159-165.
24. Jiang, B.-H., F. Agani, A. Passaniti, and G. L. Semenza. 1997. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase I: involvement of HIF-1 in tumor progression. Cancer Res. 57:5328-5335.
25. Jiang, B.-H., J. Z. Zheng, S. W. Leung, R. Roe, and G. L. Semenza. 1997. Transactivation and inhibitory domains of hypoxia-inducible factor 1α: modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272: 19253-19260.
26. Kallio, P. J., W. J. Wilson, S. O'Brien, Y. Makino, and L. Poellinger. 1999. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274:6519-6525.
27. Kern, F. G., and M. E. Lippman. 1996. The role of angiogenic growth factors in breast cancer progression. Cancer Metastasis Rev. 15:213-219.
28. Kung, A. L., S. Wang, J. M. Klco, W. G. Kaelin, and D. M. Livingston. 2000. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6:1335-1340.
29. Linderholm, B., K. Grankvist, N. Wilking, M. Johansson, B. Tavelin, and R. Henriksson. 2000. Correlation of vascular endothelial growth factor with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. J. Clin. Oncol. 18:1423-1431.
30. Linderholm, B., B. Tavelin, K. Grankvist, and R. Henriksson. 1998. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J. Clin. Oncol. 16:3121-3128.
31. Liu, W., J. Li, and R. A. Roth. 1999. Heregulin regulation of Akt/protein kinase B in breast cancer cells. Biochem. Biophys. Res. Commun. 261:897-903.
32. Liu, Y., D. el-Ashry, D. Chen, I. Y. Ding, and F. G. Kern. 1995. MCF-7 breast cancer cells overexpressing transfected c-erhB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo. Breast Cancer Res. Treat. 34:97-117.
33. Maxwell, P. H., G. U. Dachs, J. M. Gleadle, L. G. Nicholls, A. L. Harris, I. J. Stratford, O. Hankinson, C. W. Pugh, and P. J. Ratcliffe. 1997 Hypoxia-inducible factor 1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 94:8104-8109.
34. Maxwell, P. H., M. S. Wiesener, G.-W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, C. W. Pugh, E. R. Maher, and P. J. Ratcliffe. 1999. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
35. Pegram, M. D., A. Lipton, D. F. Hayes, B. L. Weber, J. M. Baselga, D. Tripathy, D. Baly, S. A. Baughman, T. Twaddell, J. A. Glaspy, and D. J. Slamon. 1998. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2 monoclonal antibody plus cisplatin in patients with HER2-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J. Clin. Oncol. 16:2659-2671.
36. Pegram, M. D., G. Pauletti, and D. J. Slamon. 1998. HER-2/neu as a predictive marker of response to breast cancer therapy. Breast Cancer Res. Treat. 52:65-77.
37. Peterson, R. T., B. N. Desai, J. S. Hardwick, and S. L. Schreiber. 1999. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycin-associated protein. Proc. Natl. Acad. Sci. USA 96:4438-4442.
38. Petit, A. M., J. Rak, M. C. Hung, P. Rockwell, N. Goldstein, B. Fendly, and R. S. Kerbel. 1997. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol. 151:1523-1530.
39. Pierce, J. H., P. Arnstein, E. DiMarco, J. Artrip, M. H. Kraus, F. Lonardo, P. P. Di Fiore, and S. A. Aaronson. 1991. Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6:1189-1194.
40. Ravi, R., B. Mookerjee, Z. M. Bhujwalla, C. H. Sutter, D. Artemov, Q. Zeng, L. E. Dillehay, A. Madan, G. L. Semenza, and A. Bedi. 2000. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev. 14:34-44.
41. Richard, D. E., E. Berra, E. Gothie, D. Roux, and J. Pouyssegur. 1999. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α(HIF-1α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274:32631-32637.
42. Richard, D. E., E. Berra, and J. Pouyssegur. 2000. Nonhypoxic pathway mediates the induction of hypoxia inducible factor 1α in vascular smooth muscle cells, J. Biol. Chem. 275:26765-26771.
43. Rilke, F., M. I. Colnaghi, N. Cascinelli, S. Andreola, M. T. Baldini, R. Bufalino, G. Della Porta, S. Menard, M. A. Pierotti, and A. Testori. 1991. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int. J. Cancer 49:44-49.
44. Ryan, H. E., J. Lo, and R. S. Johnson. 1998. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005-3015.
45. Ryan, H. E., M. Poloni, W. McNulty, D. Elson, M. Gassmann, J. M. Arbeit, and R. S. Johnson. 2000. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res. 60:4010-4015.
46. Salceda, S., and J. Caro. 1997. Hypoxia-inducible factor 1α(HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: its stabilization by hypoxia depends upon redox-induced changes. J. Biol. Chem. 272:22642-22647.
47. Salnikow, K., W. G. An, G. Melillo, M. V. Blagosklonny, and M. Costa. 1999. Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis 20:1819-1823.
48. Salnikow, K., M. Costa, W. D. Figg, and M. V. Blagosklonny. 2000 Hyper-inducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res. 60:5630-5634.
49. Semenza, G. L. 2000. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35:71-103.
50. Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
51. Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. A. Udove, A. Ullrich, et al. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
52. Sutter, C. H., and E. Laughner, and G. L. Semenza. 2000. Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc. Natl. Acad. Sci. USA 97:4748-4753.
53. Talks, K. L., H. Turley, K. C. Gatter, P. H. Maxwell, C. W. Pugh, P. J. Ralcliffe, and A. L. Harris. 2000. The expression and distribution of the hypoxia-inducible transcription factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157:411-421.
54. Tanimoto, K., Y. Makino, T. Pereira, and L. Poellinger. 2000. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19:4298-4309.
55. Tzahar, E., and Y. Yarden. 1998. The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. Biochim. Biophys. Acta 1377:M25-M37.
56. 2 tension. Proc. Natl. Acad. Sci. USA 92:5510-5514.
57. Wang, G. L., and G. L. Semenza. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1230-1237.
58. Weidner, N., J. Folkman, F. Pozza, P. Bevilacqua, E. N. Allred, D. H. Moore, S. Meli, and G. Gasparini. 1992. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84:1875-1887.
59. Weidner, N., J. P. Semple, J. R. Welch, and J. Folkman. 1991. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1-8.
60. Yen, L., X.-L. You, A.-E. Al Moustafa, G. Batist, N. E. Hynes, S. Mader, S. Meloche, M. A. Alaoui-Jamali. 2000. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene 19:3460-3469.
61. Yu, D., T. Jing, B. Liu, J. Yao, M. Tan, T. J. McDonnell, and M. C. Hung. 1998. Overexpression of ErbB2 blocks taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Mol. Cell 2:581-591.
62. Zagzag, D., H. Zhong, J. M. Scalzitti, E. Laughner, J. W. Simons, and G. L. Semenza. 2000. Expression of hypoxia-inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88:2806-2818.
63. Zelzer, E., Y. Levy, C. Kahana, B.-Z. Shilo, M. Rubinstein, and B. Cohen. 1998. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α/ARNT. EMBO J. 17:5085-5094.
64. Zetter, B. R. 1998. Angiogenesis and tumor metastasis. Annu. Rev. Med. 49:407-424.
65. Zhong, H., K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M.-M. Georgescu, J. W. Simons, and G. L. Semenza. 2000. Modulation of HIF-1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/ PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60:1541-1545.
66. Zhong, H., A. M. De Marzo, E. Laughner, M. Lim, D. A. Hilton, D. Zagzag, P. Buechler, W, B. Isaacs, G. L. Semenza, and J. W. Simons. 1999. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 59:5830-5835.
67. Zhou, B. P., M. C. T. Hu, S. A. Miller, Z. Yu, Xia, S. Y. Lin, and M. C. Hung. 2000. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-κB pathway. J. Biol. Chem. 275:8027-8031.
68. Zundel, W., C. Schindler, D. Haas-Kogan, A. Koong, F. Kaper, E. Chen, A. R. Gottschalk, H. E. Ryan, R. S. Johnson, A. B. Jefferson, D. Stokoe, and A. J. Giaccia. 2000. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14:391-396.